Pfizer announces positive top-line results from phase-III trial of pentavalent meningococcal vaccine… EP News Bureau Sep 16, 2022 Phase-III trial demonstrates that the investigational pentavalent meningococcal vaccine (MenABCWY) was well-tolerated with an…
